Autres langues Emergent BioSolutions Inc.

Actions

EBS

US29089Q1058

Marché Fermé - Nyse Autres places de cotation 22:00:02 26/04/2024			Varia. 5j.	Varia. 1 janv.
1,92 ^USD	-1,54%		-5,88%	-20,00%

24/04	Amneal Pharmaceuticals reçoit l'autorisation de la FDA de vendre la version générique d'un spray nasal pour traiter l'overdose d'opioïdes -- Les actions augmentent	MT
25/03	Emergent obtient le statut "No Action Indicated" de la FDA pour son site de production de Baltimore Bayview	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Amneal Pharmaceuticals Cleared by FDA to Sell Generic Version of Nasal Spray to Treat Opioid Overdose -- Shares Rise	24/04
Emergent BioSolutions to Release First Quarter 2024 Financial Results and Conduct Conference Call on May 1, 2024	23/04
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024	22/04
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis	28/03
Emergent Gets FDA's 'No Action Indicated' Status For Baltimore Bayview Manufacturing Facility	25/03
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility	25/03
Emergent Biosolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility	25/03
Sector Update: Health Care Stocks Rise Late Afternoon	12/03
Sector Update: Health Care Stocks Higher in Afternoon Trading	12/03
Emergent BioSolutions Tumbles After S&P Global Credit Downgrade	12/03
Emergent BioSolutions Shares Drop on S&P Downgrade	12/03
North American Morning Briefing : Stock Futures -2-	08/03
News Highlights : Top Company News of the Day - Thursday at 1 AM ET	07/03
News Highlights : Top Company News of the Day - Wednesday at 11 PM ET	07/03
News Highlights : Top Company News of the Day - Wednesday at 9 PM ET	07/03
News Highlights : Top Company News of the Day - Wednesday at 7 PM ET	07/03
Emergent Biosolutions: Q4 Earnings Snapshot	06/03
(EBS) EMERGENT BIOSOLUTIONS Sees Q1 Revenue Range $200M - $250M	06/03
Earnings Flash (EBS) EMERGENT BIOSOLUTIONS Reports Q4 Revenue $277M, vs. Street Est of $274M	06/03
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results	06/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Emergent BioSolutions Inc.

Actions

EBS

US29089Q1058

Autres langues

Filtres